Skip to main navigation Skip to search Skip to main content

A switch to Raltegravir improves antiretroviral associated hepatotoxicity in individuals co-infected with HIV and hepatitis C

M. Cevik*, I. Katsarolis, G. J. Singh, M. Nelson

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A switch to Raltegravir improves antiretroviral associated hepatotoxicity in individuals co-infected with HIV and hepatitis C'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology